Due to the lack of oversight, SIGAR determined that INL “lack an understanding” regarding the impact of its project in Afghanistan and said INL was incapable of “making informed decisions about its ongoing drug treatment projects.”
The drug lab bombing campaign in Afghanistan that was championed as a game-changer didn’t have the intended effect of hitting the Taliban’s purse and was probably a waste of resources.